Faster global financial news!
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sales growing to $67.2 billion. In contrast, Johnson & Johnson's revenue is expected to increase to $101 billion this fiscal year.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Analysis indicates that Interactive Brokers (IBKR) saw a 34% increase in client accounts last quarter, reaching 5.19 million, but a decline in global interest rates could hinder its net interest income growth.
|
Next: Analyst advises against investing in quantum computing firm IonQ, citing high valuation and rapid cash burn despite strong revenue growth
24H Trending
-
1
What is SCOP coin? Analyzing Scopuly Token and its Trading Channels
-
2
German Regional Bank Volksbank Brawo Faces Deep Trouble, May Seek Rescue Fund After CEO's Sudden May Ouster
-
3
US spot Bitcoin ETFs end 9-day inflow streak with $201.8M net outflow Friday, total assets slip below $100B as BTC dips below $78K
-
4
What is Flamingo (FLM)? A Deep Dive into its DeFi Platform and Token Acquisition Methods
-
5
BIS chief says stablecoins lack credibility for payments at scale
-
6
Turkey's Markets Regulator Tightens Rules for Hedge Funds, Limiting Related Party Exposure and Capping Concentrated Investments
-
7
Airbus seeks sale of its US space unit, shifting focus to European-built satellites after deal with Leonardo and Thales
-
8
Elon Musk reposted a tweet stating that Starlink has been granted a 10-year license to deliver satellite connectivity across the UAE
-
9
Glencore threatened with $1.4bn lawsuit from embattled trader Radiant
-
10
WGRT Token: Positioning and Market Status Analysis of WaykiChain's Governance Token
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
